Traditionally, drug discovery has focused on small molecules, but peptidic alliances are rapidly demonstrating momentum. This innovative approach involves combining peptidic sequences with alternative medicinal modalities to tackle intricate illness targets. By leveraging the distinctive features of peptides – such as significant precision and ab